Xencor, Inc. (XNCR)
22.85
-1.15
(-4.79%)
USD |
NASDAQ |
Oct 16, 16:00
22.87
+0.02
(+0.09%)
After-Hours: 20:00
Xencor Cash and Short Term Investments (Quarterly) : 456.45M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 456.45M |
| March 31, 2026 | 444.95M |
| December 31, 2025 | 547.73M |
| September 30, 2025 | 471.04M |
| June 30, 2025 | 443.86M |
| March 31, 2025 | 469.57M |
| December 31, 2024 | 497.78M |
| September 30, 2024 | 542.98M |
| June 30, 2024 | 508.41M |
| March 31, 2024 | 535.94M |
| December 31, 2023 | 593.72M |
| September 30, 2023 | 494.53M |
| June 30, 2023 | 551.37M |
| March 31, 2023 | 588.02M |
| December 31, 2022 | 621.76M |
| September 30, 2022 | 600.24M |
| June 30, 2022 | 511.92M |
| March 31, 2022 | 389.76M |
| December 31, 2021 | 333.31M |
| September 30, 2021 | 288.20M |
| June 30, 2021 | 450.05M |
| March 31, 2021 | 551.98M |
| December 31, 2020 | 601.60M |
| September 30, 2020 | 551.16M |
| June 30, 2020 | 586.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 573.90M |
| December 31, 2019 | 527.08M |
| September 30, 2019 | 546.48M |
| June 30, 2019 | 505.17M |
| March 31, 2019 | 340.36M |
| December 31, 2018 | 292.06M |
| September 30, 2018 | 271.60M |
| June 30, 2018 | 255.41M |
| March 31, 2018 | 462.41M |
| December 31, 2017 | 222.43M |
| September 30, 2017 | 209.95M |
| June 30, 2017 | 188.49M |
| March 31, 2017 | 154.79M |
| December 31, 2016 | 128.74M |
| September 30, 2016 | 104.30M |
| June 30, 2016 | 91.10M |
| March 31, 2016 | 92.36M |
| December 31, 2015 | 96.43M |
| September 30, 2015 | 127.94M |
| June 30, 2015 | 67.88M |
| March 31, 2015 | 144.24M |
| December 31, 2014 | 54.65M |
| September 30, 2014 | 60.92M |
| June 30, 2014 | 66.22M |
| March 31, 2014 | 72.54M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 79.13M |
| UroGen Pharma Ltd. | 109.30M |
| MeiraGTx Holdings Plc | 143.17M |
| IDEAYA Biosciences, Inc. | 828.96M |
| Iovance Biotherapeutics, Inc. | 297.67M |